Methyl (S)-2-(Boc-amino) -3-[(S)-2-oxo-3-pyrrolidinyl] propanoate CAS 328086-60-8 PF-07321332 Boceprevir Intermedia

Description:

Nomen chemicum: Methyl (S)-2-(Boc-amino) -3-[(S)-2-oxo-3-pyrrolidinyl]propanoatum

CAS: 328086-60-8

Aspectus: Alba ad Off-White pulveris

Intermedium PF-07321332 Paxlovid (CAS 2628280-40-8) et Boceprevir (CAS 394730-60-0);

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum Methyl (S) -2-(Boc-amino) -3-[(S)-2-oxo-3-pyrrolidinyl]propanoate
Synonyma Methyl (S) -2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl)propanoate;(αS,3S)-α-[(tert-Butyloxycarbonyl)aMino]-2-oxo-3-pyrrolidinepropanoic acid Methyl Ester;(S)-Methyl 2-((tert-butoxycarbonyl) amino) 3-((S)-2-oxopyrrolidin-3-yl) propanoate
CAS Number 328086-60-8
CATTUS Number RF-PI317
Stock Status In Stock, Productio Ascendite usque ad Centum chiliogrammata
Formulae hypotheticae C13H22N2O5
M. Pondus 286.33
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Alba ad Off-White pulveris
Lepidium sativum IR: Similia Reference substantia
Lepidium sativum B * Retention tempus: Similia Reference substantia
Damnum in Siccatio ≤1.0%
Residere in Ignition ≤0.20%
una immunditia ≤0.50%
Totalis immunditias ≤2.0%
Metalla gravia (Pb) ≤20ppm
Puritas ≥98.0%
Test Standard Enterprise Standard
Consuetudinem Intermedium PF-07321332 Paxlovid (CAS 2628280-40-8) et Boceprevir (CAS 394730-60-0);

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

1

FAQ:

Applicatio:

Methyl (S)-2-(Boc-amino) -3-[(S)-2-oxo-3-pyrrolidinyl] propanoate (CAS 328086-60-8) medium est PF-07321332 Paxlovid (CAS 2628280-40 -8) et Boceprevir (CAS 394730-60-0).PF-07321332, pars cardinis Paxlovid (PF-07321332 et Ritonavir) quae est candidatus investigationis COVID-19 oralis antiviralis, ore protease est 3C-similis protease (3CLPRO) inhibitor cum effectibus antiviralibus potentibus contra virum SARS-CoV-2 et COVID-XIX.Die 6 Nove 2021, Pfizer denuntiavit Paxlovid signanter hospitalizationem et mortem reductam, innixam analysi interim Phase 2/3 EPIC-HR (Aestimatio Proteasis Inhibitionis pro COVID-19 in aegroti High-Risk) temere, duplex studium caecum. de aegris adultis non hospitalitatis apud COVID-19, qui in magno periculo sunt progrediendi ad gravem morbum.Boceprevir (EBP-520) est inhibitor HCV protease (Ki=14 nM) ad infectio viri curationem hepatitis C.Boceprevir cum interferone et ribavirino pegylato (PegIFN/RBV) emendationem fecit in responsionis virologicis patientibus cum genotype 1 HCV.Boceprevir commercium cum therapia immunosuppressiva (IT) inhibendo cytochroma P450 3A enzyme.

Epistulam tuam hic scribe et mitte nobis